The cell surface glycoprotein L1 cell adhesion molecule (L1CAM) is implicated in tumor progression and therapy resistance across various malignancies, including ovarian cancer (OC), and its overexpression is linked to enhanced cancer stemness and correlates with poor outcomes [1]. This evidence concerns the gene L1CAM and cancer.